NCT05566392 Longterm Influence of Pediatric Long COVID Syndrome
| NCT ID | NCT05566392 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | COVID-19-Associated Encephalitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-10-20 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-10-20 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation
Eligibility Criteria
Inclusion Criteria: * Age 6-18 years old * Has been diagnosed COVID-19 before Exclusion Criteria: * History of neuropsychiatric disorders * Have some device not allowed for MRI
Contact & Investigator
Wang-Tso Lee, PHD
PRINCIPAL INVESTIGATOR
National Taiwan University Children Hospital Pediatric neurology department
Frequently Asked Questions
Who can join the NCT05566392 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying COVID-19-Associated Encephalitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05566392 currently recruiting?
Yes, NCT05566392 is actively recruiting participants. Contact the research team at leeped@hotmail.com for enrollment information.
Where is the NCT05566392 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05566392 clinical trial?
NCT05566392 is sponsored by National Taiwan University Hospital. The principal investigator is Wang-Tso Lee, PHD at National Taiwan University Children Hospital Pediatric neurology department. The trial plans to enroll 500 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.